Ingrid Kuhn-Hallek

Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.

Michael Hallek, Irmgard Langenmayer, Christoph Nerl et al. · PubMed · 1999 · 236 citations

Medicine, Hematology, Oncology +9

Serum β₂-Microglobulin and Serum Thymidine Kinase are Independent Predictors of Progression-Free Survival in Chronic Lymphocytic Leukemia and Immunocytoma

Michael Hallek, Lioba Wanders, Marianne Ostwald et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1996 · 189 citations

Medicine, Hematology, Oncology +15

Health-Related Quality of Life in Younger Patients With Chronic Lymphocytic Leukemia Treated With Fludarabine Plus Cyclophosphamide or Fludarabine Alone for First-Line Therapy: A Study by the German CLL Study Group

Barbara Eichhorst, Raymonde Busch, Tanja Obwandner et al. · Journal of Clinical Oncology · 2007 · 52 citations

Medicine, Oncology, Pharmacotherapy +12

Prognostic factors in chronic lymphocytic leukemia.

Michael Hallek, Ingrid Kuhn-Hallek, Bertold Emmerich · PubMed · 1997 · 50 citations

Medicine, Hematology, Oncology +14